Jan De Witte - 13 Feb 2023 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role
President & CEO, Director
Signature
/s/ Eric Schwartz; Attorney-in-Fact
Issuer symbol
IART
Transactions as of
13 Feb 2023
Net transactions value
$0
Form type
4
Filing time
15 Feb 2023, 15:35:07 UTC
Previous filing
19 Jan 2023
Next filing
13 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Award $0 +8,848 $0.000000 8,848 13 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date.